Compounded Medications for Autoimmune Diseases
Autoimmune diseases occur when the immune system mistakenly attacks healthy body tissues, leading to inflammation, tissue damage, and dysfunction in organs such as:
- Thyroid (Hashimoto’s disease)
- Joints (rheumatoid arthritis)
- Skin (psoriasis)
- Intestines (Crohn’s disease)
- Nerves (multiple sclerosis)
Symptoms vary by condition but commonly include:
- Fatigue
- Joint/muscle pain
- Skin rashes
- Fever
- Weight changes
- Digestive issues
- Neurological symptoms such as numbness or cognitive impairment
We develop compounded therapies to modulate immune responses, reduce inflammation, and support affected systems, offering personalized formulations that address specific autoimmune profiles for improved symptom control and quality of life.
Comprehensive Management of Autoimmune Diseases
Our tailored compounding for autoimmune diseases emphasizes immune modulation and symptom-specific support, crafting medications in gentle, bioavailable forms such as capsules, creams, or troches to enhance efficacy while minimizing side effects, integrated with lifestyle and monitoring strategies for sustained wellness and disease management.
Consider the following for comprehensive management of autoimmune diseases:
- Low-Dose Naltrexone (LDN) to regulate immune function, decrease inflammation, and alleviate pain/fatigue in conditions like MS, Crohn’s, or fibromyalgia.
- Hormone therapies such as bioidentical progesterone, DHEA, or thyroid combinations to balance endocrine disruptions common in autoimmune thyroiditis or lupus.
- Anti-inflammatory nutrient blends with compounded curcumin, omega-3s, or vitamin D in high-absorption formats to combat oxidative stress and support joint/skin health.
- Custom immunosuppressants or biologics analogs in lower doses (e.g., methotrexate alternatives) for rheumatoid or psoriatic arthritis, minimizing toxicity.
- Holistic plans including gut health probiotics, stress reduction techniques, anti-inflammatory diets, and regular autoantibody/CRP monitoring to adjust therapies based on disease activity.
